Celltrion Expands in Brazil with Omlyclo Launch, Targets Latin America Growth
Celltrion has officially begun expanding its presence in Brazil, the largest pharmaceutical market in Latin America, by hosting a launch event for its autoimmune disease treatment Omlyclo (omalizumab). The company is gaining early momentum in the market, …